EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Isoliquiritigenin ameliorates abnormal oligodendrocyte development and behavior disorders induced by white matter injury

Dong Wu, Wenjuan Zhou, Jingyi Du, Tiantian Zhao, Naigang Li, Fan Peng, Anna Li, Xinyue Zhang, Meihua Zhang, Aijun Hao

Frontiers in Pharmacology · 11.09.2024 · 15

DOI: 10.3389/fphar.2024.1473019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 11.09.2024. Verfasst von Dong Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Maternal and Fetal Medicine of National Health Commission of China, Shandong Provincial Maternal and Child Health Care Hospital Aff…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

White matter injury is a predominant form of brain injury in preterm infants. However, effective drugs for its treatment are currently lacking. Previous studies have shown the neuroprotective effects of Isoliquiritigenin (ISL), but its impact on white matter injury in preterm infants remains poorly understood.

Aims

This study aimed to investigate the protective effects of ISL against white matter injury caused by infection in preterm infants using a mouse model of lipopolysaccharide-induced white matter injury, integrating network pharmacology as well as in vivo and in vitro experiments.

Methods

This study explores the potential mechanisms of ISL on white matter injury by integrating network pharmacology. Core pathways and biological processes affected by ISL were verified through experiments, and motor coordination, anxiety-like, and depression-like behaviors of mice were evaluated using behavioral experiments. White matter injury was observed using hematoxylin-eosin staining, Luxol Fast Blue staining, and electron microscopy. The development of oligodendrocytes and the activation of microglia in mice were assessed by immunofluorescence. The expression of related proteins was detected by Western blot.

Results

We constructed a drug-target network, including 336 targets associated with ISL treatment of white matter injury. The biological process of ISL treatment of white matter injury mainly involves microglial inflammation regulation and myelination. Our findings revealed that ISL reduced early nerve reflex barriers and white matter manifestations in mice, leading to decreased activation of microglia and release of proinflammatory cytokines. Additionally, ISL demonstrated the ability to mitigate impairment in oligodendrocyte development and myelination, ultimately improving behavior disorders in adult mice. Mechanistically, we observed that ISL downregulated HDAC3 expression, promoted histone acetylation, enhanced the expression of H3K27ac, and regulated oligodendrocyte pro-differentiation factors.

Conclusion

These findings suggest that ISL can have beneficial effects on white matter injury in preterm infants by alleviating inflammation and promoting oligodendrocyte differentiation.

Schlagwörter

Stichwörter der Autor:innen

HDAC3anxietydepressionisoliquiritigeninmicrogliaoligodendrocyteswhite matter injury

Autor:innen und Institutionen

  • Key Laboratory of Maternal and Fetal Medicine of National Health Commission of China, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, China.
  • Key Laboratory for Experimental Teratology of Ministry of Education, Shandong Key Laboratory of Mental Disorders, Department of Anatomy and Histoembryology, School of Basic Medical Sciences, Cheeloo College of Medicine,…

Zitieren

APA

Wu, D., Zhou, W., Du, J., Zhao, T., Li, N., Peng, F., Li, A., Zhang, X., Zhang, M., & Hao, A. (2024). Isoliquiritigenin ameliorates abnormal oligodendrocyte development and behavior disorders induced by white matter injury. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1473019

Vancouver

Wu D, Zhou W, Du J, Zhao T, Li N, Peng F, et al. Isoliquiritigenin ameliorates abnormal oligodendrocyte development and behavior disorders induced by white matter injury. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1473019

BibTeX
@article{Wu2024,
  author = {Wu, Dong and Zhou, Wenjuan and Du, Jingyi and Zhao, Tiantian and Li, Naigang and Peng, Fan and Li, Anna and Zhang, Xinyue and Zhang, Meihua and Hao, Aijun},
  title = {Isoliquiritigenin ameliorates abnormal oligodendrocyte development and behavior disorders induced by white matter injury},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1473019}
}
Kostenlos starten →